Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Pediatr Dermatol ; 36(1): e6-e11, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30350442

ABSTRACT

Permanent epicardial pacing wires are sometimes left in place and can lead to long-term complications. We report on a case of a granulomatous reaction with a cutaneous fistula secondary to the retained epicardial pacing wires in a child and highlight the relevance of sonography as an additional tool in the diagnosis and management of dermatologic conditions.


Subject(s)
Cutaneous Fistula/etiology , Foreign Bodies/complications , Granuloma, Foreign-Body/diagnosis , Pacemaker, Artificial/adverse effects , Child , Granuloma, Foreign-Body/etiology , Humans , Male , Ultrasonography/methods
3.
PLoS One ; 13(6): e0198582, 2018.
Article in English | MEDLINE | ID: mdl-29912947

ABSTRACT

BACKGROUND: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are serious mucocutaneous reactions. In Spain, the epidemiology and resulting expenses of these diseases are not well established. METHODOLOGY: Retrospective descriptive study using the Minimum Basic Data Set (CMBD in Spanish) in patients admitted to hospitals of the National Health System between 2010 and 2015 with a diagnosis of SJS and TEN (combination of ICD-9 codes 695.13, 695.14, and 695.15, along with length of hospital stay). PRINCIPAL FINDINGS: A total of 1,468 patients were recorded, 773 were men (52.7%). The mean age (± SD) was 52.25 ± 26.15 years. The mean incidence rate for all diagnoses was 5.19 cases per million person-years (2.96 in SJS, 0.31 in SJS/TEN and 1.90 in TEN). 148 patients died (10.1%), 47 due to SJS (5.6%) and 90 (16.7%) due to TEN. The estimated total medical cost of SJS, SJS/TEN, and TEN in Spain was €11.576.456,18, and the average medical cost per patient was €7.885,86 ± €11.686,26, higher medical cost in TEN (€10352.46 ± €16319,93) than in SJS (€6340,05 ± €7078,85) (p<0.001). CONCLUSIONS: Older patients have a more severe clinical picture and higher mortality rates. The overall mortality of both diseases is approximately 10%, and clinical diagnosis and age were the variables with the greatest influence on mortality. This study describes a stable incidence and a similar prevalence to other European countries. Additionally, the data show a high cost due to hospitalizations. Finally, the CMBD could be a good system of epidemiological analysis for the study of infrequent diseases and hospital management of conditions such as SJS and TEN.


Subject(s)
Health Expenditures , Stevens-Johnson Syndrome/epidemiology , Adolescent , Adult , Age Factors , Child , Cost of Illness , Female , Health Expenditures/statistics & numerical data , Humans , Incidence , Logistic Models , Male , Middle Aged , Spain/epidemiology , Stevens-Johnson Syndrome/economics , Stevens-Johnson Syndrome/mortality , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...